Name | Auburn Manor |
---|---|
Location | 501 Oak Street, Chaska, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 61 |
Occupancy Rate | 76.89% |
Medicare ID (CCN) | 245604 |
Legal Business Name | Auburn Manor |
Ownership Type | Non Profit - Church Related |
NPI Number | 1184609448 |
Organization Name | AUBURN MANOR |
Address | 501 N Oak St, Chaska, MN 55318 |
Phone Number | 952-448-9303 |
News Archive
Women who are satisfied with everyday life and are involved in leisure activities rarely have problems with alcohol, reveals a thesis from the University of Gothenburg, Sweden.
Australian drug discovery company Bionomics Limited today updated shareholders at its Annual General Meeting on the recent progress of its anti-cancer drug BNC105 and drug discovery programs in anxiety and Multiple Sclerosis.
Texas Senate lawmakers have followed their House counterparts in approving a series of abortion restrictions. The move has opponents vowing to take their fight to the courtroom and doctors at abortion clinics are worried the legislation could force them to shut down.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
The U.S. Food and Drug Administration today approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.
› Verified 9 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Women who are satisfied with everyday life and are involved in leisure activities rarely have problems with alcohol, reveals a thesis from the University of Gothenburg, Sweden.
Australian drug discovery company Bionomics Limited today updated shareholders at its Annual General Meeting on the recent progress of its anti-cancer drug BNC105 and drug discovery programs in anxiety and Multiple Sclerosis.
Texas Senate lawmakers have followed their House counterparts in approving a series of abortion restrictions. The move has opponents vowing to take their fight to the courtroom and doctors at abortion clinics are worried the legislation could force them to shut down.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
The U.S. Food and Drug Administration today approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.
› Verified 9 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 10.74 | 14.46 |
Percentage of long-stay residents who lose too much weight | 1.32 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 56.58 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.77 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 5.35 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 5.49 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0.52 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 18.42 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.96 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 36.35 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.62 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 13.87 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 86.05 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 92.36 | 82.93 |
News Archive
Women who are satisfied with everyday life and are involved in leisure activities rarely have problems with alcohol, reveals a thesis from the University of Gothenburg, Sweden.
Australian drug discovery company Bionomics Limited today updated shareholders at its Annual General Meeting on the recent progress of its anti-cancer drug BNC105 and drug discovery programs in anxiety and Multiple Sclerosis.
Texas Senate lawmakers have followed their House counterparts in approving a series of abortion restrictions. The move has opponents vowing to take their fight to the courtroom and doctors at abortion clinics are worried the legislation could force them to shut down.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
The U.S. Food and Drug Administration today approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.
› Verified 9 days ago